微型RNA市場規模、佔有率和成長分析（按產品、服務、應用、最終用途和地區分類）－2026-2033年產業預測

預計到 2024 年，全球微型RNA市場規模將達到 15.2 億美元，到 2025 年將達到 17.2 億美元，到 2033 年將達到 45.3 億美元，在預測期（2026-2033 年）內，複合年成長率為 12.9%。

全球微型RNA市場正經歷顯著成長，這主要得益於癌症、心臟病和神經系統疾病發病率的上升，以及基因組技術的快速發展。 microRNA存在於多種體液中，已成為有效的疾病監測中極具價值的非侵入性生物標記。 microRNA在基因調控過程中發揮關鍵作用，其在血清和血漿中的穩定性增強了其診斷和預後潛力，使其成為多種人類疾病的強效生物標記。此外，存在於外泌體中的循環微型RNA可提供重要的免疫狀態數據，進一步證實了其作為健康狀況指標的重要性。人們對微型RNA在疾病診斷中的作用認知不斷提高，其效用廣泛，這支撐了強勁的市場需求，並推動了整個微型RNA產業的蓬勃發展。

全球微型RNA市場促進因素

全球微型RNA市場正受到公共和企業對基因組研究投入激增的顯著影響。這些資金支持正推動人們對微型RNA調控基因功能及其在多種疾病中的作用機制進行更深入的了解。因此，以微型RNA應用為中心的診斷和治療方法研發正在加速推進。資金的湧入不僅推動了創新，也促進了合作研究計劃的發展，為微型RNA在臨床實踐中的應用鋪平了道路。這些進展對於改善患者照護和充分發揮微型RNA技術在醫療保健領域的潛力至關重要。

限制全球微型RNA市場的因素

微型RNA的生物學複雜性對全球微型RNA市場構成重大挑戰。這種複雜性源自於微RNA分子作用機制的多樣性、與各種生物成分的相互作用，以及不同組織間的差異。這種多方面的生物學特性阻礙了特定治療標靶的精準識別，也使得科學發現轉化為實際應用變得更加複雜。因此，由於研究人員和開發人員面臨這些根本性的複雜性，標靶治療的開發困難可​​能會抑制整個微型RNA市場的成長和發展。

全球微型RNA市場趨勢

全球微型RNA市場正經歷著向聯合療法的重大轉變，其驅動力在於提高治療效果和克服抗藥性。這一趨勢強調將傳統治療方法與基於微型RNA的方法相結合，從而實現更全面的疾病治療策略。研究人員日益關注微型RNA與各種生物路徑相互作用的能力，不僅有助於提高現有藥物的療效，還能促進整體治療方案的開發。隨著我們對微型RNA功能的理解不斷加深，利用其獨特能力開發創新療法的潛力正成為市場的核心主題。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球微型RNA市場規模（依產品及複合年成長率分類）（2026-2033年）

• 裝置
  • 科技
  • 即時PCR
  • 微陣列
  • 次世代定序（NGS）
  • 其他
  • 工作流程
  • 分離/純化
  • miRNA cDNA合成
  • 分析、定位和定量
  • 函數分析及其他
  • 其他
• 消耗品
  • 檢體
  • 工作流程
  • 分離/純化
  • miRNA cDNA合成
  • 分析、定位和定量
  • 函數分析及其他
  • 其他
  • 全血
  • 血清
  • 電漿
  • FFPE
  • 新鮮冷凍組織
  • 其他

全球微型RNA市場規模（按服務類型和複合年成長率分類）（2026-2033年）

• 按類型
  • 分離/純化
  • miRNA cDNA合成
  • 分析、定位和定量
  • 功能分析
  • 其他
• 檢體
  • 全血
  • 血清
  • 電漿
  • FFPE
  • 新鮮冷凍組織
  • 其他

全球微型RNA市場規模（依應用及複合年成長率分類）（2026-2033年）

• 癌症
• 感染疾病
• 免疫疾病
• 心血管疾病
• 神經系統疾病
• 其他

全球微型RNA市場規模（按最終用途和複合年成長率分類）（2026-2033年）

• 生物技術和製藥公司
• 學術和政府研究機構
• 其他

全球微型RNA市場規模及複合年成長率（2026-2033年）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Thermo Fisher Scientific（US）
• QIAGEN（Germany）
• Illumina（US）
• Takara Bio（Japan）
• New England Biolabs（UK）
• NanoString Technologies（US）
• Merck KGaA（Germany）
• Horizon Discovery（UK）
• GeneCopoeia（US）
• Bio-Rad Laboratories（US）
• LGC Limited（UK）
• BioGenex（US）
• PerkinElmer（US）
• Agilent Technologies（US）
• Roche Holding AG（Switzerland）
• System Biosciences（US）
• MiRXES（Singapore）
• aceRNA Technologies（Japan）
• ARTHEx Biotech（Spain）

結論與建議

Global MicroRNA Market size was valued at USD 1.52 Billion in 2024 and is poised to grow from USD 1.72 Billion in 2025 to USD 4.53 Billion by 2033, growing at a CAGR of 12.9% during the forecast period (2026-2033).

The global microRNA market is witnessing significant growth driven by the increasing prevalence of cancer, heart disease, and neurological disorders, alongside rapid advancements in genomic technologies. MicroRNAs have emerged as valuable noninvasive biomarkers, as their presence in various bodily fluids enables effective disease monitoring. Recognized for their crucial role in gene regulatory processes, miRNAs serve as strong biomarkers for numerous human disorders, with their stability in serum and plasma enhancing their diagnostic and prognostic potential. Additionally, circulating miRNAs within exosomes provide insightful data on immunological conditions, reinforcing their importance as indicators of health status. This expanding recognition and utility of microRNAs in disease diagnostics underpin the robust market demand, propelling the overall growth of the microRNA industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global MicroRNA market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global MicroRNA Market Segments Analysis

Global MicroRNA Market is segmented by Products, Services, Application, End-use and region. Based on Products, the market is segmented into Instruments and Consumables. Based on Services, the market is segmented into Type and Specimen. Based on Application, the market is segmented into Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Others. Based on End-use, the market is segmented into Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global MicroRNA Market

The Global MicroRNA market is significantly influenced by the surge in public and corporate funding directed towards genomic research. This financial support is enhancing our understanding of how microRNAs regulate gene functions and contribute to various diseases. As a result, there is an accelerated development of diagnostics and treatments centered around microRNA applications. This influx of funding not only advances innovation but also promotes collaborative research projects, paving the way for the integration of microRNAs into clinical practices. Such advancements are crucial for enhancing patient care and harnessing the full potential of microRNA technology in the medical field.

Restraints in the Global MicroRNA Market

The intricate nature of MicroRNA biology poses a significant challenge for the global microRNA market. The complexities arise from the diverse modes of action and interactions these molecules exhibit with various biological components, along with the variability observed across different tissues. This multifaceted biology can hinder the precise identification of specific treatment targets, complicating the translation of scientific discoveries into practical applications. As a result, the difficulties in developing targeted therapies may restrain the overall growth and advancement of the microRNA market, as researchers and developers grapple with these underlying complexities.

Market Trends of the Global MicroRNA Market

The Global MicroRNA market is witnessing a significant shift towards combination therapies, driven by the quest for enhanced treatment outcomes and the need to overcome drug resistance. This trend emphasizes the integration of traditional treatments alongside microRNA-based approaches, allowing for a more multifaceted strategy in addressing diseases. Researchers are increasingly focusing on the ability of microRNAs to interact with various biological pathways, thereby not only improving the efficacy of existing pharmaceutical options but also promoting a holistic therapeutic approach. As the understanding of microRNA functions deepens, the potential for innovative treatments leveraging their unique capabilities is becoming a central theme in the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global MicroRNA Market Size by Products & CAGR (2026-2033)

• Market Overview
• Instruments
  • Technology
  • Real Time PCR
  • Microarray
  • NGS
  • Others
  • Workflow
  • Isolation & Purification
  • miRNA cDNA Synthesis
  • Profiling, Localization, & Quantification
  • Functional Analysis & Others
  • Others
• Consumables
  • Specimen
  • Workflow
  • Isolation & Purification
  • miRNA cDNA Synthesis
  • Profiling, Localization, & Quantification
  • Functional Analysis & Others
  • Others
  • Whole Blood
  • Serum
  • Plasma
  • FFPE
  • Fresh Frozen Tissue
  • Others

Global MicroRNA Market Size by Services & CAGR (2026-2033)

• Market Overview
• Type
  • Isolation & Purification
  • miRNA cDNA Synthesis
  • Profiling, Localization, & Quantification
  • Functional Analysis
  • Others
• Specimen
  • Whole Blood
  • Serum
  • Plasma
  • FFPE
  • Fresh Frozen Tissue
  • Others

Global MicroRNA Market Size by Application & CAGR (2026-2033)

• Market Overview
• Cancer
• Infectious Diseases
• Immunological Disorder
• Cardiovascular Disease
• Neurological Disease
• Others

Global MicroRNA Market Size by End-use & CAGR (2026-2033)

• Market Overview
• Biotechnology & Pharmaceutical Companies
• Academic & Government Research Institutes
• Others

Global MicroRNA Market Size & CAGR (2026-2033)

• North America (Products, Services, Application, End-use)
  • US
  • Canada
• Europe (Products, Services, Application, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Products, Services, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Products, Services, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Products, Services, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NanoString Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horizon Discovery (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneCopoeia (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LGC Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioGenex (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• System Biosciences (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MiRXES (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• aceRNA Technologies (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARTHEx Biotech (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations